ESR1 and breast cancer: In an in silico analysis, the lncRNA MALINC1, upregulated in CDIS lesions, showed the presence of 4 ER binding sites (EREs) close to the transcription start site, indicating that, in breast cancer, its expression may be modulated by estrogen [72].